These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 28336088)
1. Trends in ADHD medication use in children and adolescents in five western countries, 2005-2012. Bachmann CJ; Wijlaars LP; Kalverdijk LJ; Burcu M; Glaeske G; Schuiling-Veninga CCM; Hoffmann F; Aagaard L; Zito JM Eur Neuropsychopharmacol; 2017 May; 27(5):484-493. PubMed ID: 28336088 [TBL] [Abstract][Full Text] [Related]
2. Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases. Raman SR; Man KKC; Bahmanyar S; Berard A; Bilder S; Boukhris T; Bushnell G; Crystal S; Furu K; KaoYang YH; Karlstad Ø; Kieler H; Kubota K; Lai EC; Martikainen JE; Maura G; Moore N; Montero D; Nakamura H; Neumann A; Pate V; Pottegård A; Pratt NL; Roughead EE; Macias Saint-Gerons D; Stürmer T; Su CC; Zoega H; Sturkenbroom MCJM; Chan EW; Coghill D; Ip P; Wong ICK Lancet Psychiatry; 2018 Oct; 5(10):824-835. PubMed ID: 30220514 [TBL] [Abstract][Full Text] [Related]
3. Five-fold increase in national prevalence rates of attention-deficit/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit/hyperactivity disorder, and other psychiatric disorders: a Danish register-based study. Dalsgaard S; Nielsen HS; Simonsen M J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):432-9. PubMed ID: 24015896 [TBL] [Abstract][Full Text] [Related]
4. Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study. Wong IC; Asherson P; Bilbow A; Clifford S; Coghill D; DeSoysa R; Hollis C; McCarthy S; Murray M; Planner C; Potts L; Sayal K; Taylor E Health Technol Assess; 2009 Oct; 13(50):iii-iv, ix-xi, 1-120. PubMed ID: 19883527 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. Goldman LS; Genel M; Bezman RJ; Slanetz PJ JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570 [TBL] [Abstract][Full Text] [Related]
6. Trends in attention-deficit and hyperactivity disorder (ADHD) medications among children and young adults in Ireland: a repeated cross-sectional study from 2005 to 2015. Mac Avin M; Teeling M; Bennett KE BMJ Open; 2020 Apr; 10(4):e035716. PubMed ID: 32327478 [TBL] [Abstract][Full Text] [Related]
7. ADHD Drug Prescribing Trend Is Increasing Among Children and Adolescents in Hong Kong. Man KKC; Ip P; Hsia Y; Chan EW; Chui CSL; Lam MPS; Wong WHS; Chow CB; Yung A; Wong ICK J Atten Disord; 2017 Dec; 21(14):1161-1168. PubMed ID: 24994875 [TBL] [Abstract][Full Text] [Related]
8. [Time Trends in the Frequencies of ADHD and Stimulant Medication]. Steinhausen HC; Döpfner M; Schubert I Z Kinder Jugendpsychiatr Psychother; 2016; 44(4):275-84. PubMed ID: 27434688 [TBL] [Abstract][Full Text] [Related]
9. Patterns of psychostimulant prescribing to children with ADHD in Western Australia: variations in age, gender, medication type and dose prescribed. Preen DB; Calver J; Sanfilippo FM; Bulsara M; Holman CD Aust N Z J Public Health; 2007 Apr; 31(2):120-6. PubMed ID: 17461001 [TBL] [Abstract][Full Text] [Related]
10. Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005-2012. Bachmann CJ; Aagaard L; Burcu M; Glaeske G; Kalverdijk LJ; Petersen I; Schuiling-Veninga CC; Wijlaars L; Zito JM; Hoffmann F Eur Neuropsychopharmacol; 2016 Mar; 26(3):411-9. PubMed ID: 26970020 [TBL] [Abstract][Full Text] [Related]
11. Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995-2015. Renoux C; Shin JY; Dell'Aniello S; Fergusson E; Suissa S Br J Clin Pharmacol; 2016 Sep; 82(3):858-68. PubMed ID: 27145886 [TBL] [Abstract][Full Text] [Related]
12. Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence. Beau-Lejdstrom R; Douglas I; Evans SJ; Smeeth L BMJ Open; 2016 Jun; 6(6):e010508. PubMed ID: 27297009 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of prescribed attention-deficit hyperactivity disorder medications and diagnosis among Canadian preschoolers and school-age children: 1994-2007. Brault MC; Lacourse É Can J Psychiatry; 2012 Feb; 57(2):93-101. PubMed ID: 22340149 [TBL] [Abstract][Full Text] [Related]
14. ADHD in Germany: Trends in Diagnosis and Pharmacotherapy. Bachmann CJ; Philipsen A; Hoffmann F Dtsch Arztebl Int; 2017 Mar; 114(9):141-148. PubMed ID: 28351466 [TBL] [Abstract][Full Text] [Related]
15. The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007. Schubert I; Köster I; Lehmkuhl G Dtsch Arztebl Int; 2010 Sep; 107(36):615-21. PubMed ID: 20948775 [TBL] [Abstract][Full Text] [Related]
18. Influence of Age, Gender, and Living Circumstances on Patterns of Attention-Deficit/Hyperactivity Disorder Medication Use in Children and Adolescents With or Without Intellectual Disabilities. Osunsanmi S; Turk J J Child Adolesc Psychopharmacol; 2016 Nov; 26(9):828-834. PubMed ID: 26982546 [TBL] [Abstract][Full Text] [Related]
19. Trends in attention-deficit/hyperactivity disorder drug consumption in children and adolescents in Slovenia from 2001 to 2012: a drug use study from a national perspective. Štuhec M; Locatelli I; Švab V J Child Adolesc Psychopharmacol; 2015 Apr; 25(3):254-9. PubMed ID: 25803789 [TBL] [Abstract][Full Text] [Related]
20. Review of medication adherence in children and adults with ADHD. Adler LD; Nierenberg AA Postgrad Med; 2010 Jan; 122(1):184-91. PubMed ID: 20107302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]